#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Severe myoclonic epilepsy of infancy Herpes simplex Short stature homeobox gene mutation Staphylococcal infection Chronic myeloid leukaemia Immune-mediated enterocolitis Glomerulonephritis membranoproliferative Corneal neovascularisation Philadelphia positive acute lymphocytic leukaemia Liver abscess Giant cell tumour of tendon sheath NTRK gene fusion overexpression Deafness neurosensory Neurofibroma Follicle centre lymphoma follicular grade I, II – III More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency Undifferentiated sarcoma – Basic Information Tuberous sclerosis complex – Basic Information Angiosarcoma non-metastatic – Treatment Leiomyosarcoma metastatic – Life with Disease IgA nephropathy Retinoblastoma – Basic Information Netherton’s syndrome Lennox-Gastaut syndrome – Treatment Richter’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bay 3283142 Ads-010 Palonosetron Hydrochloride Fezolinetant Tretinoin Lumateperone Lutetium (177Lu)-Neobomb1 Efanesoctocog Alfa Afimetoran Besilate Dihydrate Epoetin Alfa Tolebrutinib Bi 764524 Relacorilant AMG 732 Op-1250 Ravulizumab Triptorelin Pamoate Cft1946 Magnesium Oxybate Raludotatug Deruxtecan More therapies…

    Learn about Your Condition

    Micrographic skin surgery Dyspepsia Aortic valve disease Kearns-Sayre syndrome Laryngeal leukoplakia Nasal sinus cancer Pharyngeal cancer stage III Gastric cancer stage IV Syphilis Left ventricular failure Ejection fraction normal Primary amyloidosis Head and neck cancer stage III Hyponatraemia Eosinophilic gastritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Copper (64Cu) Chloride
    Italy

  • Study on Bone Marrow Cells and Saline for Treating Severe Limb Ischemia in Patients at High Risk of Amputation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Saline
    Spain

  • Study on Allogeneic Umbilical Cord Mesenchymal Stromal Cells for Treating Chronic Kidney Transplant Rejection in Adult Patients

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Transplant rejection
    Investigated Drugs:
    • ALLOGENEIC UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS EX VIVO EXPANDED
    France

  • Study of dabigatran, apixaban and edoxaban for prevention of stroke recurrence in patients with acute ischemic stroke without known atrial fibrillation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Dabigatran Etexilate
    • Edoxaban
    • Clopidogrel
    Greece Spain

  • Study on Lung Function After Pulmonary Embolism Using Galligas and 68Ga-MAA in Patients with Pulmonary Embolism

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • GRAPHITE
    • Human Albumin As Macroaggregates
    France

  • Study on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Infliximab
    Finland
Previous Page
1 … 830 831 832 833 834 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!